Area of research
Epidemiology · Public Health, Environmental and Occupational Health
Research interest
Research focused on Opioid use disorder and Buprenorphine, with related work in Naltrexone, Transcranial magnetic stimulation, Randomized controlled trial. Notable publications include 'Gender differences in demographic and clinical characteristics of patients with opioid use disorder entering a comparative effectiveness medication trial', 'LONG-TERM EFFICACY OF REPEATED DAILY PREFRONTAL TRANSCRANIAL MAGNETIC STIMULATION (TMS) IN TREATMNT-RESISTANT DEPRESSION', and 'The Painfulness of Active, but not Sham, Transcranial Magnetic Stimulation Decreases Rapidly Over Time: Results From the Double-Blind Phase of the OPT-TMS Trial'.
Polysubstance use before and during treatment with medication for opioid use disorder: Prevalence and association with treatment outcomes
Sublingual Buprenorphine-Naloxone Compared With Injection Naltrexone for Opioid Use Disorder: Potential Utility of Patient Characteristics in Guiding Choice of Treatment
Naturalistic follow-up after a trial of medications for opioid use disorder: Medication status, opioid use, and relapse
Young Adults Have Worse Outcomes Than Older Adults: Secondary Analysis of a Medication Trial for Opioid Use Disorder
Trajectory classes of opioid use among individuals in a randomized controlled trial comparing extended-release naltrexone and buprenorphine-naloxone
Gender differences in demographic and clinical characteristics of patients with opioid use disorder entering a comparative effectiveness medication trial
The Painfulness of Active, but not Sham, Transcranial Magnetic Stimulation Decreases Rapidly Over Time: Results From the Double-Blind Phase of the OPT-TMS Trial
LONG-TERM EFFICACY OF REPEATED DAILY PREFRONTAL TRANSCRANIAL MAGNETIC STIMULATION (TMS) IN TREATMNT-RESISTANT DEPRESSION